Ronkonkoma, New York, USA – TheNewswire – G6 Materials Corp. (TSXV:GGG) (OTC:GPHBF) (“G6”) announces that it expects to file its annual financial statements and accompanying management’s discussion and analysis for the financial year ended May 31, 2021 (collectively, the “Annual Filings”) on or before October 27th 2022. G6 will continue to provide biweekly status updates on the delay of filing its Annual Filings.

 

G6 confirms that since it announced a delay of its Annual Filings on September 29, 2022 (the “Filings Notice”) there is no material change to the information set out in the Filings Notice that has not been generally disclosed and there has been no failure by the Company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203. Management is working diligently to meet the Company’s obligations relating to its Annual Filings and that, while subject to the Management Cease Trade Order issued on September 29, 2022 (“MCTO”), the Company will continue to comply with the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly status reports until it has satisfied the necessary filing requirements.

  

About G6 Materials Corp.

 

G6 Materials Corp. is a high-tech company with expertise in advanced materials that creates value developing innovative composites for a wide range of industrial uses. Graphene Laboratories Inc., a wholly owned subsidiary of G6, sells a range of graphene-based products and other materials, including but not limited to conductive epoxies, high-performance composites, and R&D materials, with numerous customers from among the Fortune 500 list of companies, as well as NASA and leading universities. Graphene Laboratories Inc. has entered the global air filtration market with Breathe+, a line of medical grade HEPA air filtration products enhanced with advanced performance graphene material.

 

G6 has identified new graphene-based applications to accelerate growth into the future. Accordingly, the Company has a valuable IP portfolio currently comprising five granted patents. The Company’s management team and employees have a deep understanding of graphene technology based on decades of aggregate academic and commercial experience. Graphene Laboratories Inc., a wholly owned subsidiary of G6 located in Ronkonkoma, New York, has established its premium research laboratory and scalable production facility is equipped with advanced analytical and material processing equipment.

 

The Company’s e-commerce websites are listed below:

 

• ●●Breathe: Medical grade HEPA air filtration enhanced with advanced performance graphene material, for more information, visit www.breatheplus.tech 

• ●●Conductive Epoxies: Adhesive materials distributed under the G6-EpoxyTM trade name and can be purchased at www.g6-epoxy.com 

• ●●D Materials: Graphene Laboratories Inc. currently offers over 100 graphene and related products available at www.graphene-supermarket.com 

   

Contact Details:

 

Commercial Inquiries:

Telephone: (631) 405-5113

Email: info@g6-materials.com

 

Investor Inquiries:

 

Telephone:  1-(866)-324-4244

Email: investors@g6-materials.com

 

ON BEHALF OF THE BOARD:  Daniel Stolyarov, President & Co-CEO

 

For more information on G6 Materials Corp., please visit www.G6-Materials.com or its profile page on SEDAR at www.sedar.com.

   

Forward-Looking Information

 

Except for the statements of historical fact, this news release contains “forward-looking information” within the meaning of the applicable Canadian securities legislation that is based on expectations, estimates and projections as at the date of this news release. “Forward-looking information” in this news release includes, but is not limited to, the timing, review, completion and filing of the Annual Filings, and duration of the MCTO; the long term growth, business goals and objectives of the Company, and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon.

 

Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to, the Company will be subject to a general cease trade order in the event that the Annual Filings are not completed and filed in a timely manner; and other related risks as more fully set out in the continuous disclosure filings under the Company’s profile at www.sedar.com.

  

The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about the Company’s ability to complete and file the Annual Filings. The Company has also assumed that no significant events occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein. Forward-looking information herein will not be updated unless required by law.

  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.